GHX Business Continuity Updatedate: 25 March 2020
Since outlining GHX’s Business Continuity Plans (BCP) on 13th March, we have continued to monitor global operations and are reporting no change at this time. Our goal is to ensure our network of healthcare providers and suppliers is efficiently and effectively operating their supply chain processes, and order flow and transactions remain stable.
To ensure we’re achieving these goals, GHX regularly measures four global indicators: (1) service availability; (2) workforce productivity; (3) change management; and (4) offshore delivery.
We have seen supply chain transactions slightly increase in the last 30 days, but performance, throughput and availability are working as expected with room to scale.
There have been no changes in business continuity as our workforce operates on a fully remote basis where applicable. Our critical technology vendors and partners have also confirmed there is no change in their operations and continue to service GHX normally. Additionally, we are closely monitoring changing directives from local governments pertaining to work from home and the definition of “key workers.”
Minimal Change Period
Given the dynamic nature of the global response to COVID-19 and its impact on our customers, we have increased our focus on product release planning and change management:
- While critical maintenance and commercial releases are being prioritised, we are also proactively assessing risk mitigation measures.
- GHX has also committed more resources to actively monitoring post-release validation to swiftly address any issues that may arise.
To date, we have seen no cases of COVID-19 in the global geographies where our processing centres are located. Should we experience a severe deterioration of services from our offshore facilities in the future, we are prepared to move Gfax processing onshore. We continue to leverage full remote workforce capabilities where applicable.